Showing results (71-80 of 138) with videos related to
Sort By:
Pageof 14
Diabetes & Metabolism|February 16, 2010
Bariatric surgery in young massively obese diabetic patientsC Ciangura, A BasdevantLa Revue Du Praticien|December 15, 1993
[Pharmacology of estrogens used in the treatment of menopause]A Basdevant, G PanotopoulosAtherosclerosis|December 1, 1990
Hormonal influences on the relationships between body fatness, body fat distribution, lipids, lipoproteins, glucose and blood pressure in French working womenJ Raison, C Bonithon-Kopp, M Egloff, et al.Journal of Clinical Epidemiology|January 1, 1991
Skinfold and body circumferences as measures of body fat patterning in a French female active population: relationships with the metabolic risk profileC Bonithon-Kopp, J Raison, M Egloff, et al.La Revue De Medecine Interne|May 1, 1989
[International study of the effect of dexfenfluramine in obesity (ISIS): 6 months' results]B Guy-Grand, M Apfelbaum, G Crepaldi, et al.Atherosclerosis|October 19, 1999
Evidence for a cholesteryl ester donor activity of LDL particles during alimentary lipemia in normolipidemic subjectsT S Lassel, M Guerin, S Auboiron, et al.Annales De Medecine Interne|June 1, 1976
[Paradoxical effects of iodine overload on thyroid function]B Bigorie, P Guillausseau, A Leger, et al.The Journal of Clinical Investigation|July 21, 2000
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesityC Vaisse, K Clement, E Durand, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 1998
Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjectsT S Lassel, M Guérin, S Auboiron, et al.Lancet (London, England)|November 11, 1989
International trial of long-term dexfenfluramine in obesityB Guy-Grand, M Apfelbaum, G Crepaldi, et al.Pageof 14